Analgesic effects of dexmedetomidine in vincristine-evoked painful neuropathic rats

Hue Jung Park, Young Hoon Kim, Hyun Jung Koh, Chul Soo Park, Seung Hee Kang, Jong Ho Choi, Dong Eon Moon

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Dexmedetomidine, which is a selective α2-adrenoceptor agonist, was recently introduced into clinical practice for its analgesic properties. The purpose of this study was to evaluate the effects of dexmedetomidine in a vincristine-evoked neuropathic rat models. Sprague-Dawley rats were injected intraperitoneally with vincristine or saline (0.1 mg/kg/day) using a 5-day-on, 2-day-off schedule for 2 weeks. Saline and dexmedetomidine (12.5, 25, 50, and 100 μg/kg) were injected to rats developed allodynia 14 days after vincristine injection, respectively. We evaluated allodynia at before, 15, 30, 60, 90, 120, 180, and 240 min, and 24 hr after intraperitoneal drug (normal saline or dexmedetomidine) injection. Saline treatment did not show any differences for all the allodynia. Maximal paw withdrawal thresholds to mechanical stimuli were 3.0 ± 0.4, 9.1 ± 1.9, 13.0 ± 3.6, 16.6 ± 2.4, and 24.4 ± 1.6 g at saline, 12.5, 25, 50, and 100 μg/kg dexmedetomidine injection, respectively. Minimal withdrawal frequency to cold stimuli were 73.3 ± 4.2, 57.1 ± 6.8, 34.3 ± 5.7, 20.0 ± 6.2, and 14.3 ± 9.5 g at saline, 12.5, 25, 50, and 100 μg/kg dexmedetomidine injection, respectively. Dexmedetomidine shows a dose-dependent anti-allodynic effect on mechanical and cold stimuli in vincristine-evoked neuropathic rat models (P < 0.05).

Original languageEnglish
Pages (from-to)1411-1417
Number of pages7
JournalJournal of Korean Medical Science
Volume27
Issue number11
DOIs
StatePublished - 2012

Keywords

  • Dexmedetomidine
  • Neuropathy
  • Pain
  • Vincristine

Fingerprint

Dive into the research topics of 'Analgesic effects of dexmedetomidine in vincristine-evoked painful neuropathic rats'. Together they form a unique fingerprint.

Cite this